Bifidobacterium bifidum S17

Names Bifidobacterium bifidum S17
Accession numbers NC_014616
Background Bifidobacteria represent an important group of the intestinal microbiota of humans and are believed to be promising candidates for pharmaceutical applications and functional food products due to their ability to exclude intestinal pathogens, strengthen the intestinal barrier, and/or modulate the immune response in the intestine. Bifidobacterium bifidum (strain S17) is a Gram-positive bacterium isolated from feces of a breast-fed infant. It is shown to strongly adhere to intestinal epithelial cells and has potent anti-inflammatory activity in vitro and in vivo. (Adapted from PMID: 21037011). (EBI Integr8)
Strain S17
Complete Yes
Sequencing centre (10-SEP-2010) Institute of Microbiology and Biotechnology, University of Ulm, Albert-Einstein-Allee 11, Ulm
(22-OCT-2010) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Sequencing quality Level 6: Finished
Sequencing depth NA
Sequencing method 454-GS-FLX
Isolation site faeces of a breast-fed infant
Isolation country NA
Number of replicons 1
Gram staining properties Positive
Shape Bacilli
Mobility No
Flagellar presence No
Number of membranes 1
Oxygen requirements Anaerobic
Optimal temperature NA
Temperature range Mesophilic
Habitat HostAssociated
Biotic relationship Free living
Host name Homo sapiens
Cell arrangement NA
Sporulation Nonsporulating
Metabolism NA
Energy source NA
Diseases NA
Pathogenicity No